← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Antiger Therapeutics Inc.
St Louis, MO
$869,457
Total funding
3
Grants
Funding over time
peak $303.3K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$869,457 · 3
By mechanism
R43$869,457 · 3
Investigators at Antiger Therapeutics Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Peptide-HLA-DQ8 biologics for antigen-specific therapy in Type 1 Diabetes$303,274
R43 · FY2025 · AI
Peptide-HLA-DQ2 biologics for antigen-specific therapy in Celiac Disease$293,680
R43 · FY2024 · AI
Class II Human Leukocyte Antigen biologics for antibody-mediated graft rejection.$272,503
R43 · FY2023 · AI